Shengyou Lin

544 total citations
38 papers, 371 citations indexed

About

Shengyou Lin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shengyou Lin has authored 38 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shengyou Lin's work include Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (4 papers) and Colorectal and Anal Carcinomas (4 papers). Shengyou Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (4 papers) and Colorectal and Anal Carcinomas (4 papers). Shengyou Lin collaborates with scholars based in China, Germany and Taiwan. Shengyou Lin's co-authors include Jinhua Lu, Wenlong Wang, Bisha Ding, Weiyang Lou, Wenlong Wang, Hongda Lu, Qingzhi Kong, Kaibo Guo, Yuqian Feng and Jiangyan Xu and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Journal of Cellular Biochemistry.

In The Last Decade

Shengyou Lin

33 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengyou Lin China 12 176 121 105 94 35 38 371
Xiaobo Xu China 13 217 1.2× 169 1.4× 167 1.6× 59 0.6× 49 1.4× 29 461
Shih-Hsin Hsiao Taiwan 13 202 1.1× 199 1.6× 204 1.9× 103 1.1× 33 0.9× 29 491
Akash Gupta United States 11 157 0.9× 100 0.8× 50 0.5× 53 0.6× 31 0.9× 41 412
Dongdong Zhou China 12 210 1.2× 99 0.8× 46 0.4× 146 1.6× 33 0.9× 29 389
Ravat Panvichian Thailand 11 192 1.1× 130 1.1× 88 0.8× 79 0.8× 14 0.4× 18 356
Hengzi Sun China 12 181 1.0× 52 0.4× 57 0.5× 101 1.1× 30 0.9× 22 343
Linfei Hu China 13 268 1.5× 104 0.9× 68 0.6× 119 1.3× 43 1.2× 34 451
Shuai Chen China 11 143 0.8× 64 0.5× 75 0.7× 79 0.8× 36 1.0× 32 292
Namrata Khurana United States 10 192 1.1× 66 0.5× 79 0.8× 77 0.8× 59 1.7× 13 352

Countries citing papers authored by Shengyou Lin

Since Specialization
Citations

This map shows the geographic impact of Shengyou Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyou Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyou Lin more than expected).

Fields of papers citing papers by Shengyou Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyou Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyou Lin. The network helps show where Shengyou Lin may publish in the future.

Co-authorship network of co-authors of Shengyou Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyou Lin. A scholar is included among the top collaborators of Shengyou Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyou Lin. Shengyou Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Feng, Yuqian, et al.. (2025). Mesenchymal stem cells for lung diseases: focus on immunomodulatory action. Cell Death Discovery. 11(1). 52–52.
4.
Jiang, Jin, Yuqian Feng, Ying Zhao, et al.. (2024). Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches. Combinatorial Chemistry & High Throughput Screening. 28(11). 1872–1887.
5.
Lv, Xiang, et al.. (2024). Single‐cell and spatial transcriptomics reveal apelin/APJ pathway's role in microvessel formation and tumour progression in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 28(20). e70152–e70152. 5 indexed citations
6.
Feng, Yuqian, et al.. (2024). Adverse events of neoadjuvant combination immunotherapy for resectable cancer patients: a systematic review and meta-analysis. Frontiers in Immunology. 14. 1269067–1269067. 4 indexed citations
7.
Feng, Yuqian, et al.. (2024). Berberine: Potential preventive and therapeutic strategies for human colorectal cancer. Cell Biochemistry and Function. 42(4). e4033–e4033. 8 indexed citations
8.
Ni, Cui, et al.. (2024). Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis. Frontiers in Pharmacology. 15. 1322473–1322473. 1 indexed citations
9.
Jiang, Jin, Yu Zhang, Jun Wang, et al.. (2023). Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. PeerJ. 11. e16166–e16166. 3 indexed citations
10.
Feng, Yuqian, Kaibo Guo, Jing Jiang, & Shengyou Lin. (2023). Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases. Biomedicine & Pharmacotherapy. 170. 116008–116008. 19 indexed citations
11.
Lu, Jinhua, et al.. (2023). Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?. Clinics and Research in Hepatology and Gastroenterology. 47(2). 102078–102078. 2 indexed citations
12.
Wu, Jian, Zhaobin Cai, Haijun Huang, et al.. (2022). Effects of Different Therapeutic Schedules on Patients with COVID-19: A Prospective Case–Control Study in China. 2022. 1–10. 4 indexed citations
13.
Jiang, Jin, Ting Huang, Yu Zhang, et al.. (2022). Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report. Frontiers in Oncology. 12. 896024–896024. 3 indexed citations
14.
15.
Fang, Xiaojie, et al.. (2021). Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis. International Journal of Colorectal Disease. 37(1). 251–258. 15 indexed citations
16.
Wang, Jue, et al.. (2020). Guilu Erxian Glue (龟鹿二仙胶) Inhibits Chemotherapy-Induced Bone Marrow Hematopoietic Stem Cell Senescence in Mice May via p16INK4a-Rb Signaling Pathway. Chinese Journal of Integrative Medicine. 26(11). 819–824. 9 indexed citations
17.
Lu, Jinhua, et al.. (2020). Jiawei Xianglian Decoction (JWXLD), a Traditional Chinese Medicine (TCM), Alleviates CPT‐11‐Induced Diarrhea in Mice. Evidence-based Complementary and Alternative Medicine. 2020(1). 7901231–7901231. 12 indexed citations
18.
19.
Lu, Jinhua, Zhaohui Chen, Xuping Wu, et al.. (2017). Baicalin alleviates radiation-induced epithelial-mesenchymal transition of primary type II alveolar epithelial cells via TGF-β and ERK/GSK3β signaling pathways. Biomedicine & Pharmacotherapy. 95. 1219–1224. 35 indexed citations
20.
Zheng, Ruzhen, Zonghao You, Shengyou Lin, et al.. (2015). Efficacy of percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma. Genetics and Molecular Research. 14(4). 17982–17994. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaobo Xu Breakdown of academic impact, for papers by Shih-Hsin Hsiao Breakdown of academic impact, for papers by Akash Gupta Breakdown of academic impact, for papers by Dongdong Zhou Breakdown of academic impact, for papers by Ravat Panvichian Breakdown of academic impact, for papers by Hengzi Sun Breakdown of academic impact, for papers by Linfei Hu Breakdown of academic impact, for papers by Shuai Chen Breakdown of academic impact, for papers by Namrata Khurana
Rankless by CCL
2026